Article Information
History
- January 23, 2023.
Article Versions
- Version 1 (January 14, 2023 - 18:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Wehuai Tao1,2,3,
- Yiqiu Wei1,2,3,
- Zhihuan Ye1,2,3,
- Jianxue Wang1,
- Weixin Yang1,
- Guoxing Yu1,2,3,
- Jieyi Xiong*,4,5 and
- Shiqi Jia*,1,2,3
- 1The First Affiliated Hospital of Jinan University, Guangzhou, China
- 2The Guangdong-Hong Kong-Macao Joint University Laboratory of Metabolic and Molecular Medicine, Jinan University, Guangzhou, China
- 3The Institute of Clinical Medicine, Jinan University, Guangzhou, China
- 4Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- 5VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium
- ↵*Corresponding author: Shiqi Jia, Phone: +86-20-3868 0563, Email: shiqijia{at}jnu.edu.cn, Jieyi Xiong, Phone: +32 478 11 49 46, Email: jieyi.xiong{at}kuleuven.be
# These authors contribute equally to this work
Posted January 23, 2023.
